Effect of rituximab on B cell phenotype and serum B cell-activating factor levels in patients with thrombotic thrombocytopenic purpura.

Saved in:
Bibliographic Details
Title: Effect of rituximab on B cell phenotype and serum B cell-activating factor levels in patients with thrombotic thrombocytopenic purpura.
Authors: Becerra, E.1, Scully, M. A.2, Leandro, M. J.1, Heelas, E. O.2, Westwood, J.‐P.2, De La Torre, I.3, Cambridge, G.1
Source: Clinical & Experimental Immunology. Mar2015, Vol. 179 Issue 3, p414-425. 12p. 1 Chart, 5 Graphs.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:00099104
DOI:10.1111/cei.12472